More Updates to Come of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial: Could the Statistical Methodology Be Further Improved?

J Clin Oncol. 2023 May 1;41(13):2450-2451. doi: 10.1200/JCO.22.02839. Epub 2023 Mar 10.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Child
  • Humans
  • Immunotherapy, Adoptive / methods
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma*
  • Receptors, Antigen, T-Cell*
  • Young Adult

Substances

  • tisagenlecleucel
  • Receptors, Antigen, T-Cell